Hikal Ltd share price logo

Hikal Ltd

NSE: HIKAL

BSE: 524735

Small Cap

Pharma Sector

₹181.10

-6.03

(-3.22%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Hikal Stock Performance

as on April 24, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹179.50
    ₹188.37
    downward going graph

    0.88%

    Downside

    4.01%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹146.25
    ₹449.25
    downward going graph

    19.24%

    Downside

    148.07%

    Upside

    downward going graph

Hikal share price movements today

Previous Close
₹187.13
Open
₹188.37
Volume
2.61L
Upper Circuit
₹224.55
Lower Circuit
₹149.71
Day's Low - High
₹179.50 - ₹188.37
52 Week Low - High
₹146.25 - ₹449.25

Hikal Historical Returns

1 Month Return
+ 16.18 %
3 Month Return
-6.5 %
1 Year Return
-54.65 %
3 Year Return
-37.69 %
5 Year Return
-16.98 %

Hikal Fundamentals

as on April 24, 2026 at 4:01 pm IST

Market Cap

₹2,232.98 Cr

Return on Equity (ROE)

7.42

PE Ratio (TTM)

-170.85

Return on capital employed (ROCE)

9.49

Industry PE ratio

42.79

Beta (LTM)

1.03

P/B Ratio

3.91

Dividend Yield

0.2

PEG Ratio

24.06

Quarterly Earnings Growth YOY

-134.3

EPS (TTM)

7.35

Sector

Pharmaceuticals

Book Value

102.21

Technical Analysis

Bullish

Hikal Stock Valuation

as on April 24, 2026 at 4:01 pm IST

Hikal in the last 5 years

  • Overview

  • Trends

Lowest (-214.11x)

January 2, 2026

Today (-170.85x)

April 24, 2026

Industry (42.79x)

April 24, 2026

Highest (316.23x)

December 10, 2025

LowHigh

Today’s Price to Earnings Ratio: -170.85x

Hikal Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Hikal with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Hikal Ltd image
Hikal Ltd
BUY2,232.98-3.4%0.70901,859
Cohance Lifesciences Ltd image
Cohance Lifesciences Ltd
BUY13,776.24-6.81%0.682641,197
Jubilant Pharmova Ltd image
Jubilant Pharmova Ltd
BUY15,060.223.46%0.718367,234
Sun Pharma Advanced Research Company Ltd image
Sun Pharma Advanced Research Company Ltd
BUY4,519.94-3.71%1.88-34371
Rainbow Childrens Medicare Ltd image
Rainbow Childrens Medicare Ltd
BUY12,616.6935.19%0.672441,515
See all

Market expectation of Hikal Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

50.00%

Buy

50.00%

Hold

0.00%

Sell

Hikal Stock’s Investor Sentiment and Interest

Search interest for Hikal Ltd Stock has increased by 6% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:6% versus previous 30 day period

Hikal Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
386.1
431.23
438.5
512.8
403.8
450.8
438.9
550
371.3
316.2
490.7
Other Income
0.9
0.99
0.1
0.5
0.5
0.4
3.6
0.5
1
1.9
2.8
Total Income
388.9
435.87
447.6
514.6
407.3
453.3
451.3
552.9
381.4
320.4
497.1
Expenses
337.7
377.36
382.8
419.7
348.8
378
375.6
429
355.3
311.3
449.6
Operating Profit
48.4
53.87
55.7
93.1
55
72.8
63.3
121
16
4.9
41.1
Operating Profit Margin %
12.54%
12.49%
12.7%
18.16%
13.62%
16.15%
14.42%
22%
4.31%
1.55%
8.38%
Profit Before Interest, Tax and Depreciation
51.2
58.51
64.8
94.9
58.5
75.3
75.7
123.9
26.1
9.1
47.5
Interest
13.8
13.08
14.2
15.3
19.8
18.8
18.7
17.9
17.1
14.9
15.5
Depreciation
27.7
28.57
29
32.3
31.8
31.7
33.2
37.7
39.4
41.2
41.2
Profit Before Tax
9.7
16.86
21.6
47.3
6.9
24.8
23.8
68.3
-30.4
-47
-9.2
Tax Paid
2.8
4.29
5.5
13.4
1.8
6.5
6.6
18.1
-8
-12.1
-3.3
Profit After Tax
6.9
12.57
16.1
33.9
5.1
18.3
17.2
50.2
-22.4
-34.9
-5.9
Total Net profit including share of profit / Loss from associate company
6.9
12.57
16.1
33.9
5.1
18.3
17.2
50.2
-22.4
-34.9
-5.9
EPS
0.56
1.02
1.31
2.76
0.41
1.48
1.39
4.07
-1.82
-2.83
-0.48
Actual EPS
0.56
1.02
1.31
2.76
0.41
1.48
1.39
4.07
-1.82
-2.83
-0.48
Adjusted EPS
0.56
1.02
1.31
2.76
0.41
1.48
1.39
4.07
-1.82
-2.83
-0.48
Diluted EPS
0.56
1.02
1.31
2.76
0.41
1.48
1.39
4.07
-1.82
-2.83
-0.48

Hikal Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
1,278.35
1,567.74
1,462.12
1,707.06
1,926.03
2,004.7
1,768.7
1,843.5
Other Income
4.46
2.26
3.7
4.98
4.89
5.41
2.5
5
Total Income
1,300.56
1,591.87
1,510.96
1,725.42
1,947.61
2,028.44
1,787.1
1,864.8
Expenses
1,054.35
1,291.49
1,249.51
1,397.55
1,602.16
1,765.96
1,517.6
1,531.4
Operating Profit
224
276.25
212.61
309.51
323.87
238.74
251.1
312.1
Operating Profit Margin %
17.52%
17.62%
14.54%
18.13%
16.82%
11.91%
14.2%
16.93%
Profit Before Interest, Tax and Depreciation
246.21
300.38
261.45
327.87
345.45
262.48
269.5
333.4
Interest
49.12
58.43
52.42
36.2
31.21
48.1
56.4
75.2
Depreciation
85.59
92.88
82.46
85.24
95.67
109.01
117.6
134.4
Profit Before Tax
111.5
149.07
126.57
206.43
218.57
105.37
95.5
123.8
Tax Paid
34.27
46.01
42.14
73.28
58.06
26.98
25.9
33
Profit After Tax
77.23
103.06
84.43
133.15
160.51
78.39
69.6
90.8
Total Net profit including share of profit / Loss from associate company
77.23
103.06
84.43
133.15
160.51
78.39
69.6
90.8
EPS
9.4
8.36
6.85
10.8
13.02
6.36
5.64
7.36
Actual EPS
9.4
8.36
6.85
10.8
13.02
6.36
5.64
7.36
Adjusted EPS
6.27
8.36
6.85
10.8
13.02
6.36
5.64
7.36
Diluted EPS
9.4
8.36
6.85
10.8
13.02
6.36
5.64
7.36

Hikal Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
185.61
163.48
138.81
185.59
284.93
229.02
293.73
315.31
186.72
280.4
Cash Flow from Investing Activities
-63.91
-102.17
-110.12
-124.59
-163.79
-156.2
-284.37
-292.33
-173.75
-136.5
Cash Flow from Financing Activities
-123.63
-63.28
-24.79
-55.41
-100.87
-96.87
-5.56
-7.68
-27
-143.6
Net Cash Flow
-1.93
-1.96
3.9
5.59
20.27
-24.05
3.8
15.29
-14.03
0.3

Hikal Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Promoters
68.85%
68.85%
68.85%
68.85%
68.85%
68.85%
68.85%
68.85%
68.85%
68.85%
68.85%
68.85%
DII
2.78%
3.12%
3.15%
3.53%
3.17%
3.58%
3.48%
3.8%
4.02%
5.16%
7.05%
7.2%
FII
0%
4.81%
6.13%
6.55%
6.67%
6.78%
6.06%
5.69%
5.36%
4.23%
2.3%
1.43%
Public
23.8%
23.22%
21.86%
21.07%
21.32%
20.79%
21.61%
21.66%
21.77%
21.76%
21.79%
22.52%
Total Outstanding Shares
12,33,00,750
12,33,00,750
12,33,00,750
12,33,00,750
12,33,00,750
12,33,00,750
12,33,00,750
12,33,00,750
12,33,00,750
12,33,00,750
12,33,00,750
12,33,00,750
Total Shareholders
75,110
76,126
74,657
71,840
70,978
71,912
71,801
68,907
71,391
73,404
74,117
74,270

Mutual Funds that own Hikal Stock

Check out the Mutual Funds with significant holdings in Hikal.

Hikal Corporate Actions

View detailed summary of the earnings and dividend history of Hikal.

  • Hikal Ltd Earnings Results

    Hikal Ltd’s net profit fell -134.3% since last year same period to ₹-5.90Cr in the Q3 2025-2026. On a quarterly growth basis, Hikal Ltd has generated 83.09% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Hikal Ltd Dividends February,2026

    In the quarter ending December 2025, Hikal Ltd has declared dividend of ₹0.20 per share on 11 Feb 2026 - translating a dividend yield of 0.55%.

    Read More about Dividends

Indices Featuring Hikal Stock

Check stock indices that include Hikal.

BSE Healthcare

₹43,616.92

-1.35 (▲597.52%)

Insights on Hikal Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 5.71% to 5.92% in Mar 2026 quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 21.79% to 22.52% in Mar 2026 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -34.9 Cr → -5.9 Cr (in ₹), with an average increase of 491.5% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 320.4 Cr → 497.1 Cr (in ₹), with an average increase of 35.6% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Lupin Ltd has given 224.5% return, outperforming this stock by 262.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 23.5% return, outperforming this stock by 78.1%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 68.85% of holdings in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, HIKAL stock has moved down by -54.7%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 2.30% to 1.43% in Mar 2026 quarter

About Hikal Ltd

Hikal Limited is an Indian-based company, incorporated in 1988, with global recognition in the pharmaceutical, crop protection, animal health, biocides and specialty chemicals industries. It has 5 manufacturing facilities in 3 states, producing various chemical intermediates, active pharma ingredients, APIs and contract research activities. With their multiple partnerships and technological expansion projects, they have achieved milestones such as receiving the 5 Star Safety Award from the UK British Safety Council and their promotion to a trading house status. They have acquired an agrochemical manufacturing site from Novartis India Limited, which was followed by an investment in a JV with a Sinochem Corporation China subsidiary. Furthermore, they provide human and animal health products, amongst others. Recent developments such as the long-term contracts with life science companies, the sale of the RD unit and the bonus share issuance to shareholders indicate the company's success.

Revenue: ₹490.70Cr as on December 2025 (Q3 FY26)
Net Profit: ₹-5.90Cr as on December 2025 (Q3 FY26)
Listing date: 14 Feb, 2001
Chairperson Name: Jai Hiremath
OrganisationHikal Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOJai Hiremath
E-voting on sharesClick here to vote

FAQs

What is Hikal share price today?

Hikal share price today stands at ₹181.1 as on at the close of the market. Hikal share today touched a day high of ₹188.37 and a low of ₹179.5.

What is the 52 week high and 52 week low range for Hikal share?

Hikal touched a 52 week high of ₹449.25 and a 52 week low of ₹146.25. Hikal share price today i.e. is closed at ₹181.1, which is -59.69% down from its 52 week high and 23.83% up from its 52 week low.

What is Hikal's market capitalisation today?

Hikal market capitalisation is ₹2,232.98 Cr as on .

How to buy Hikal shares?

To buy Hikal shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for HIKAL or Hikal Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Hikal shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Hikal trading volume today?

Hikal trading volume is 2.61L as on . This means that 2.61L shares of Hikal were bought and sold on the stock market during today's trading session.